Skip to main content
. 2020 Oct 17;80(18):1929–1946. doi: 10.1007/s40265-020-01421-w
The effectiveness of antiviral and immune therapies was inconsistent in most cases of COVID-19.
To date, remdesivir, dexamethasone, and baricitinib represent the best therapeutic option.
The promising results of efficacy of anakinra need confirmation by the ongoing RCTs.